The presence of aberrant p53 pattern is a negative prognostic predictor in squamous cell carcinoma of the nasal vestibule
The aim of this study was to analyze the role of Ki-67, p53, and the “aberrant p53 pattern” in squamous cell carcinomas of the nasal vestibule. Patients between 1995 and 2014 were included. Baseline characteristics and outcome were analyzed with respect to immunohistochemical staining of Ki-67 and p53. “Aberrant p53 pattern” was represented by a moderate or strong staining of at least 60% of the tumor cells or a complete absence of immunoreactivity. Forty-six patients were included of whom 31 (67.4%) were available for Ki-67 and 32 (69.9%) for p53 immunohistochemistry. The “aberrant pattern” of p53 was present in 50% of the patients. While immunoreactivity for both Ki-67 and p53 was not related to each other or outcome, the “aberrant p53 pattern” was associated with a worse disease-free survival (p = 0.014). The “aberrant p53 pattern” is a negative prognostic factor in squamous cell carcinoma of the nasal vestibule and might enable a patient-tailored treatment.
KeywordsSquamous cell carcinoma Nasal vestibule p53 Aberrant pattern Ki-67 Predictor
Compliance with ethical standards
This work was supported by the KFSP Tumor Oxygenation of the University of Zurich.
Conflicts of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the local authority’s research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
According to the Swiss national law, informed consent is required for this type of retrospective study for all individuals included after January 1, 2014 and was obtained in these cases. For all others, formal consent is not required unless there is a general refusal to be included in retrospective studies.
- 1.Agger A, von Buchwald C, Madsen AR, Yde J, Lesnikova I, Christensen CB, Foghsgaard S, Christensen TB, Hansen HS, Larsen S, Bentzen J, Andersen E, Andersen L, Grau C (2009) Squamous cell carcinoma of the nasal vestibule 1993–2002: a nationwide retrospective study from DAHANCA. Head Neck 31:1593–1599CrossRefPubMedGoogle Scholar
- 27.Mazeron JJ, Chassagne D, Crook J, Bachelot F, Brochet F, Brune D, Brunin F, Bunescu U, Daly N, Danczak S (1988) Radiation therapy of carcinomas of the skin of nose and nasal vestibule: a report of 1676 cases by the Groupe Europeen de Curiethérapie. Radiother Oncol 13:165–173CrossRefPubMedGoogle Scholar
- 36.Sobin L, Wittekind C (2005) TNM classification of malignant tumors. Wiley, New York, p 120Google Scholar
- 37.Sobin LH, Gospodarowicz MK, Wittekind C (2009) Tnm classification of malignant tumours. Wiley, New York, p 165Google Scholar
- 51.Yemelyanova A, Vang R, Kshirsagar M, Lu D, Marks MA, Shih IM, Kurman RJ (2011) Immunohistochemical staining patterns of p53 can serve as a surrogate marker for tp53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis. Mod Pathol 24:1248–1253CrossRefPubMedGoogle Scholar
- 52.Zatonski T, Ciesielska U, Nowinska K, Ratajczak-Wielgomas K, Kobierzycki C, Pula B, Podhorska-Okolow M, Krecicki T, Dziegiel P (2016) Expression of cell cycle-related proteins p16, p27, p53 and ki-67 in hpv-positive and -negative samples of papillomas of the upper respiratory tract. Anticancer Res 36:3917–3924PubMedGoogle Scholar